tiprankstipranks
Trending News
More News >
Lifco Ab (SE:LIFCO.B)
:LIFCO.B

Lifco Ab (LIFCO.B) AI Stock Analysis

Compare
5 Followers

Top Page

SE:LIFCO.B

Lifco Ab

(LIFCO.B)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
kr385.00
â–²(9.44% Upside)
Lifco Ab's overall stock score reflects strong financial performance as the most significant factor, supported by efficient operations and stable capital structure. However, the stock's valuation appears high, and technical indicators suggest potential short-term weakness.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term expansion and stability.
Cash Generation
Strong cash generation enhances financial flexibility, enabling reinvestment in growth opportunities and resilience against economic downturns.
Profitability
High profitability margins reflect efficient operations and pricing power, contributing to sustained earnings and competitive advantage.
Negative Factors
Rising Debt Levels
Increasing debt levels can strain financial resources and limit the company's ability to invest in growth or weather economic challenges.
Cost Pressures
Declining gross margins suggest rising costs, which could pressure profitability if not managed effectively, impacting long-term financial health.
Operating Cash Flow
A decrease in operating cash flow coverage may indicate potential liquidity challenges, affecting the company's ability to fund operations and growth.

Lifco Ab (LIFCO.B) vs. iShares MSCI Sweden ETF (EWD)

Lifco Ab Business Overview & Revenue Model

Company DescriptionLifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, Asia, Australia, North America, and internationally. It is involved in the distribution of dental equipment, such as disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory. In addition, it develops, manufactures, and sells demolition robots, and crane and excavator attachments to construction and earthworks, snow clearing, demolition, pipe and cable laying, forestry work, scrap handling and railway works. Further, the company engages in the contract manufacturing of electronic components, stainless steel products, and galvanized products for use in the security and alarm, industrial applications, telecom and IT, food products, and pharmaceutical industries; and the waste handling and recycling of tires, wires, refrigerators, aluminum products, and electronics. Additionally, it offers vehicle racking systems for service vans; equipment for sawing and handling of sawn lumber, as well as pellet mills; cleaning and sealing of pipes, as well as electrical supplies, and LED-lighting and measuring instruments for the surveying and construction industries; and telecom equipment to fiber market and aluminum cabinets. The company was founded in 1946 and is based in Enköping, Sweden. Lifco AB (publ) is a subsidiary of Carl Bennet AB.
How the Company Makes MoneyLifco AB generates revenue through multiple streams, primarily from the sale of its products in the aforementioned sectors. The Dental segment earns income through the sale of dental equipment, instruments, and consumables to dental practices and clinics, while the Demolition & Tools segment derives revenue from providing specialized tools and equipment for construction and demolition activities. Additionally, the Systems solutions segment contributes to earnings by offering customized solutions and support services to various industrial clients. The company also benefits from strategic partnerships with suppliers and distributors, enhancing its market reach and product offerings, which further supports its revenue generation efforts.

Lifco Ab Financial Statement Overview

Summary
Lifco Ab demonstrates strong financial performance with consistent revenue and profit growth, efficient operations, and a stable capital structure. However, attention is needed on rising debt levels and maintaining cost efficiencies.
Income Statement
85
Very Positive
Lifco Ab demonstrates strong revenue growth with a TTM growth rate of 2.05% and consistent profitability, evidenced by a solid gross profit margin of 43.91% and a net profit margin of 12.51%. The EBIT and EBITDA margins are healthy at 18.36% and 22.18%, respectively, indicating efficient operations. However, the slight decline in gross profit margin from the previous year suggests potential cost pressures.
Balance Sheet
78
Positive
The company maintains a moderate debt-to-equity ratio of 0.63, reflecting a balanced approach to leveraging. Return on equity is robust at 19.24%, showcasing effective use of equity capital. The equity ratio stands at 44.61%, indicating a stable capital structure. Nonetheless, the increasing debt levels over the years could pose future risks if not managed carefully.
Cash Flow
80
Positive
Lifco Ab's cash flow performance is strong, with a free cash flow growth rate of 4.86% in the TTM period. The operating cash flow to net income ratio of 0.37 and free cash flow to net income ratio of 0.91 highlight efficient cash generation relative to earnings. The consistent growth in free cash flow suggests a solid cash position, though the operating cash flow coverage ratio has slightly decreased, indicating potential areas for improvement.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue27.84B26.14B24.45B21.55B17.48B13.78B
Gross Profit12.23B11.59B10.82B9.01B7.33B5.81B
EBITDA6.52B6.66B5.08B5.13B4.08B3.03B
Net Income3.56B3.30B3.27B2.78B2.39B1.67B
Balance Sheet
Total Assets41.79B38.89B34.29B29.77B24.88B18.26B
Cash, Cash Equivalents and Short-Term Investments1.47B1.52B1.59B1.70B1.51B1.17B
Total Debt11.85B10.36B9.52B8.26B6.91B4.92B
Total Liabilities23.01B20.48B18.96B16.43B14.12B9.59B
Stockholders Equity18.64B18.26B15.21B13.24B10.64B8.61B
Cash Flow
Free Cash Flow4.30B3.95B4.02B2.72B2.63B2.55B
Operating Cash Flow4.69B4.49B4.46B3.07B2.94B2.81B
Investing Cash Flow-4.74B-3.34B-4.16B-2.72B-3.29B-1.30B
Financing Cash Flow-99.00M-1.40B-346.00M-308.00M573.00M-998.00M

Lifco Ab Technical Analysis

Technical Analysis Sentiment
Positive
Last Price351.80
Price Trends
50DMA
350.08
Negative
100DMA
342.25
Positive
200DMA
356.86
Negative
Market Momentum
MACD
-0.29
Negative
RSI
50.38
Neutral
STOCH
56.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LIFCO.B, the sentiment is Positive. The current price of 351.8 is above the 20-day moving average (MA) of 347.11, above the 50-day MA of 350.08, and below the 200-day MA of 356.86, indicating a neutral trend. The MACD of -0.29 indicates Negative momentum. The RSI at 50.38 is Neutral, neither overbought nor oversold. The STOCH value of 56.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:LIFCO.B.

Lifco Ab Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
kr16.10B20.4014.17%2.48%0.40%38.42%
69
Neutral
kr159.79B44.8519.96%0.68%9.39%10.45%
69
Neutral
kr83.76B16.6113.13%3.09%-0.74%6.55%
66
Neutral
kr8.34B34.7414.16%1.90%9.65%19.40%
66
Neutral
kr25.36B14.5714.28%3.66%2.58%19.07%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
48
Neutral
kr8.47B-117.00-3.67%1.27%4.65%-136.09%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:LIFCO.B
Lifco Ab
351.80
33.51
10.53%
SE:LOOMIS
Loomis AB
382.80
51.60
15.58%
SE:SECU.B
Securitas AB
146.20
13.10
9.85%
SE:NOLA.B
Nolato AB
59.75
6.55
12.32%
SE:BERG.B
Bergman & Beving AB Class B
317.00
9.24
3.00%
SE:VOLO
Volati AB
105.00
13.32
14.53%

Lifco Ab Corporate Events

Lifco AB Acquires UK-Based DB Orthodontics
Nov 25, 2025

Lifco AB has acquired DB Orthodontics Ltd, a UK-based company that produces and sells orthodontic materials to dental professionals globally. The acquisition, which will be consolidated into Lifco’s Dental business area in the fourth quarter of 2025, is not expected to significantly impact Lifco’s earnings or financial position this year.

Lifco AB Proposes New Board Member Anders Oscarsson
Nov 20, 2025

Lifco AB’s Nomination Committee has proposed Anders Oscarsson for the Board of Directors, replacing Axel Wachtmeister, who will not seek re-election in 2026. Oscarsson’s extensive experience in equities and owner relations at AMF is expected to bring valuable insights to Lifco’s strategic direction, potentially impacting its operations and stakeholder relations positively.

Lifco AB Expands with Acquisition of HEGUtechnik GmbH
Nov 3, 2025

Lifco AB has acquired a majority stake in HEGUtechnik GmbH, a German niche contract manufacturer specializing in electronic components for automation in harsh industrial environments. This acquisition, which will be consolidated into Lifco’s Business Area Systems Solutions, is not expected to significantly impact Lifco’s financials this year but strengthens its position in the contract manufacturing sector.

Lifco AB Reports Strong Growth and Strategic Acquisitions in 2025
Oct 24, 2025

Lifco AB reported a 9.0% increase in net sales to SEK 20,717 million for the first nine months of 2025, driven by acquisitions and organic growth. The company consolidated 13 new businesses, enhancing its market position, and maintained a strong financial position with interest-bearing net debt at 1.3 times EBITDA, allowing for potential future acquisitions.

Lifco Expands Dental Portfolio with Acquisition of Nobil Bio Ricerche
Oct 3, 2025

Lifco AB has announced the acquisition of a majority stake in Nobil Bio Ricerche, an Italian company specializing in customizing implant surfaces for dental manufacturers. This acquisition, set to be consolidated in Lifco’s Dental business area by the fourth quarter of 2025, is not expected to significantly impact Lifco’s financial performance for the current year. The move aligns with Lifco’s strategy of expanding its portfolio in niche markets, potentially enhancing its industry positioning and offering additional growth opportunities.

Lifco AB Acquires Citodent Imaging to Enhance Dental Business
Sep 11, 2025

Lifco AB has announced the acquisition of a majority stake in Citodent Imaging B.V., a Dutch company specializing in software for managing X-ray and diagnostic imaging for dentists in Europe. The acquisition, which will be integrated into Lifco’s Dental business area by the third quarter of 2025, is not expected to significantly impact Lifco’s earnings or financial position for the current financial year.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 27, 2025